logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Chu of Liège

+3243230000
dermatologie@chuliege.be
Source: Site record.
https://www.chuliege.be

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

Located in the heart of the university campus, Sart Tilman is the largest site of Liège University Hospital (CHU de Liège). The administrative headquarters of CHU de Liège are also located there.

Business Status

Source: Human-provided. OPEN

Business Category

Source: Human-provided. University hospital

Business Subcategory

Source: Human-provided. University hospital
Source: Trial-derived.
226Total Trials
Source: Trial-derived.
42Recruiting Trials
Source: Trial-derived.
51Active Trials
Source: Trial-derived.
1Completed Trials
Source: Trial-derived.
279Unique Conditions
Source: Trial-derived.
198Unique Sponsors

Conditions

Source: Trial-derived. Crohn's Disease (11)Source: Trial-derived. Carcinoma, Non-Small-Cell Lung (5)Source: Trial-derived. Crohn Disease (5)Source: Trial-derived. Multiple Myeloma (5)Source: Trial-derived. Acute Myeloid Leukemia (4)Source: Trial-derived. Advanced Solid Tumors (4)Source: Trial-derived. Idiopathic Pulmonary Fibrosis (4)Source: Trial-derived. Interstitial Lung Disease (4)

Sponsors

Source: Trial-derived. AbbVie (29)Source: Trial-derived. University of Liege (29)Source: Trial-derived. The Lymphoma Academic Research Organisation (11)Source: Trial-derived. Bayer (9)Source: Trial-derived. Merck Sharp & Dohme LLC (9)Source: Trial-derived. Centre Hospitalier Universitaire de Liege (6)Source: Trial-derived. Hoffmann-La Roche (6)Source: Trial-derived. Janssen Research & Development, LLC (6)

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Electronic source (eSource) system

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Spirometry
Source: AI-inferred. CT Scan
Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. Full pulmonary function lab (DLCO / plethysmography)
Source: AI-inferred. Six-minute walk test
Source: AI-inferred. 12-lead ECG
Source: AI-inferred. MRI
Source: AI-inferred. Vibration-controlled transient elastography (FibroScan)

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. Histology / pathology
Source: AI-inferred. Specimen packaging and shipment
Source: AI-inferred. PCR / molecular
Source: AI-inferred. ELISA / immunoassay
Source: AI-inferred. Pharmacokinetic bioanalysis

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling
Source: AI-inferred. Sterile preparation (laminar-flow hood / BSC or cleanroom)

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Endoscopy / colonoscopy
Source: AI-inferred. Radiation therapy
Source: AI-inferred. Liver biopsy
Source: AI-inferred. Surgery / operating room

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Electronic patient-reported outcome (ePRO) diary system
Source: AI-inferred. EGFR mutation and ALK rearrangement testing
Source: AI-inferred. Enhanced Liver Fibrosis (ELF) testing
Source: AI-inferred. Left ventricular ejection fraction assessment
Source: AI-inferred. Supplemental oxygen administration